| Identification | Back Directory | [Name]
7H-Pyrrolo[2,3-d]pyridazin-7-one, 4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1,6-dihydro-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- | [CAS]
2762750-70-7 | [Synonyms]
FGFR-IN-5
7H-Pyrrolo[2,3-d]pyridazin-7-one, 4-amino-3-[2-(2-cyclopropyl-5-benzoxazolyl)ethynyl]-1,6-dihydro-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- | [Molecular Formula]
C25H22N6O3 | [MOL File]
2762750-70-7.mol | [Molecular Weight]
454.48 |
| Hazard Information | Back Directory | [Uses]
FGFR-IN-5 is a potent inhibitor of FGFR. Fibroblast growth factor receptor (FGFR) is a tyrosine kinase receptor that binds to fibroblast growth factor ligands. FGFR-IN-5 has the potential for the research of cancer diseases (extracted from patent WO2022042612A1, compound 3)[1]. FGFR-IN-5 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | [References]
[1] Haibin Deng, et al. Dihydropyrrolo[2,3-d]pyridazin-7-one derivative, preparation method therefor, and application thereof. Patent WO2022042612A1. |
|
|